Similar articles for PMID: 18214042

Year	Number of Results
1984	1
1992	1
1997	1
1998	1
1999	2
2000	1
2001	1
2004	2
2005	3
2006	4
2007	7
2008	37
2009	30
2010	1
2011	2
2012	1
2013	2
2014	1
2015	1
2017	1
2023	0

1

High incidence of GalNAc disialosyl lactotetraosylceramide in metastatic renal cell carcinoma.

Maruyama R, Saito S, Bilim V, Hara N, Itoi T, Yamana K, Nishiyama T, Arai Y, Takahashi K, Tomita Y. Maruyama R, et al. Anticancer Res. 2007 Nov-Dec;27(6C):4345-50. Anticancer Res. 2007. PMID: 18214042 Free article.

2

Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.

Klatte T, Seligson DB, Riggs SB, Leppert JT, Berkman MK, Kleid MD, Yu H, Kabbinavar FF, Pantuck AJ, Belldegrun AS. Klatte T, et al. Clin Cancer Res. 2007 Dec 15;13(24):7388-93. doi: 10.1158/1078-0432.CCR-07-0411. Clin Cancer Res. 2007. PMID: 18094421

3

Prognostic evaluation of COX-2 expression in renal cell carcinoma.

Kankuri-Tammilehto MK, Söderström KO, Pelliniemi TT, Vahlberg T, Pyrhönen SO, Salminen EK. Kankuri-Tammilehto MK, et al. Anticancer Res. 2010 Jul;30(7):3023-30. Anticancer Res. 2010. PMID: 20683050

4

Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers.

Minervini A, Di Cristofano C, Gacci M, Serni S, Menicagli M, Lanciotti M, Salinitri G, Rocca CD, Lapini A, Nesi G, Bevilacqua G, Minervini R, Carini M. Minervini A, et al. J Urol. 2008 Oct;180(4):1284-9. doi: 10.1016/j.juro.2008.06.036. Epub 2008 Aug 15. J Urol. 2008. PMID: 18707725

5

Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.

Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M. Ohno Y, et al. Oncol Rep. 2008 Sep;20(3):511-6. Oncol Rep. 2008. PMID: 18695899

6

Characterization of primary renal carcinoma cultures.

Sievers E, Dreimuller P, Haferkamp A, Schmidt-Wolf IG, Buchler MW, Schmidt J, Marten A. Sievers E, et al. Urol Int. 2007;79(3):235-43. doi: 10.1159/000107956. Urol Int. 2007. PMID: 17940356

7

Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis.

Schrader AJ, Rustemeier J, Varga Z, Hegele A, Olbert PJ, Frohme C, Hofmann R. Schrader AJ, et al. Int J Urol. 2009 Sep;16(9):718-22. doi: 10.1111/j.1442-2042.2009.02353.x. Epub 2009 Jul 29. Int J Urol. 2009. PMID: 19659680

8

Costimulatory molecule B7-H1 in primary and metastatic clear cell renal cell carcinoma.

Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED. Thompson RH, et al. Cancer. 2005 Nov 15;104(10):2084-91. doi: 10.1002/cncr.21470. Cancer. 2005. PMID: 16208700 Free article.

9

Increased RANKL expression is related to tumour migration and metastasis of renal cell carcinomas.

Mikami S, Katsube K, Oya M, Ishida M, Kosaka T, Mizuno R, Mochizuki S, Ikeda T, Mukai M, Okada Y. Mikami S, et al. J Pathol. 2009 Aug;218(4):530-9. doi: 10.1002/path.2567. J Pathol. 2009. PMID: 19455604

10

Reappraisal of T3N0/NxM0 renal cell carcinoma: significance of extent of fat invasion, renal vein invasion, and adrenal invasion.

Jung SJ, Ro JY, Truong LD, Ayala AG, Shen SS. Jung SJ, et al. Hum Pathol. 2008 Nov;39(11):1689-94. doi: 10.1016/j.humpath.2008.04.011. Epub 2008 Jul 24. Hum Pathol. 2008. PMID: 18656240

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed